On August 25, 2026, two Dutch ministers sent a response to Parliament whose implications extend far beyond the country’s borders. The acquisition of the largest grower in the Dutch cannabis experiment by a corporation in which tobacco giant Altria holds approximately 41 percent cannot be prevented under current law. The reason is not negligence on the part of individual authorities, but rather a gap between two regulatory frameworks that were never designed to interact with each other.
📑 Inhaltsverzeichnis
A greenhouse in Voorne aan Zee and 57.5 million euros
CanAdelaar was founded in 2018 and operates approximately 50,000 square meters of greenhouse space in Voorne aan Zee, formerly Hellevoetsluis. The operation holds the largest market share and supplies nearly all participating coffeeshops. Revenue increased from 17.7 million US dollars in 2024 to 47.3 million the following year.
On December 9, 2025, Canadian Cronos Group announced the acquisition for 57.5 million euros. CEO Mike Gorenstein spoke of establishing a strategic presence in Europe. Altria, in turn, holds approximately 41 percent of Cronos—the corporation behind Philip Morris USA and thus behind the Marlboro brand in the American market. The deadline for closing has since been extended to September 9, 2026, in part due to an ongoing Bibob review.
How the Cabinet answers twelve questions
CDA representatives Krul and Van den Brink had submitted twelve questions. Health Minister Hermans and Justice Minister Van Weel responded on August 25. The central statement is soberly worded yet far-reaching. The statutory framework contains no provision excluding participation based on the background of shareholders.
The Cabinet identifies the Bibob review as a control mechanism. It runs every two to three years, and a change in ownership structure can trigger a new investigation. However, this review focuses on integrity and the risk of criminal entanglement. Health policy considerations explicitly do not factor into its standards. Therefore, it cannot stand against the commercial interests of a completely legally operating tobacco corporation.
Otherwise, the government points to existing safeguards such as advertising bans and packaging requirements. It rejects stricter rules. The fact that parliamentarians demand oversight of a young regulated market through inquiries is not a specifically Dutch phenomenon, as recently demonstrated by questions from nine parliamentarians regarding Infarmed licenses in Portugal.
Article 5.3 of the WHO tobacco convention does not apply here
For tobacco, there is an international instrument that specifically addresses this case. Article 5.3 of the WHO Framework Convention on Tobacco Control obligates contracting parties to protect their health policies from the commercial interests of the tobacco industry. The Netherlands and Germany are both parties to the convention.
The Cabinet now states that this provision does not apply to cannabis. Because cannabis remains illegal under the Opium Act, tobacco law regulations likewise do not apply. Thus, a smokable product falls through both regulatory frameworks. It is not tobacco, so tobacco law does not apply. It is a drug, so drug law applies, but drug law contains no provision regarding ownership.
This gap is not an oversight by individual officials. The two regulatory frameworks developed independently of each other, decades apart and without consideration for one another. Only when a state actually regulates cultivation do they intersect. Then it becomes clear that no one anticipated this scenario.
Consolidation has already begun
Ten growers were selected by lottery, and all had to pass the Bibob review. The lottery system was intended to prevent capital strength from determining access. However, it only regulates entry into the experiment, not the subsequent sale of shares.
Moreover, CanAdelaar would not be the first operation in North American hands. Leli Holland belongs to Village Farms, a company listed on the Nasdaq. Of ten growers, two would thus be controlled by listed corporations from overseas. For an experiment intended to test a closed and manageable supply chain, this represents a remarkable shift. We described how the experiment was originally structured when the sales phase began in the participating coffeeshops.
Additionally, there is a local dispute. The municipality of Voorne aan Zee is pressing for operational adjustments due to odor nuisance and has contacted the responsible ministries. The experiment’s largest grower thus faces pressure from two directions.
What Germany and Switzerland can learn from this
In Germany, the Cannabis Consumption Act currently only regulates the non-commercial pathway. Cultivation associations are prohibited from making profits, so the question of shareholders simply does not arise there. The associations themselves are now pushing for a clear boundary between medical and recreational use, which further sharpens the debate around commercial structures.
The situation would be different with regional pilot projects, which were envisioned as the second pillar of legalization and have yet to be implemented. A commercial pilot project would have no restriction comparable to association law. Who may hold shares there must be specified in the legislation itself, not merely appear in a tender.
Switzerland conducts its trials through public and non-profit entities, which is why the legal channel there was able to displace the black market without investors being involved. The ownership question returns the moment an experiment becomes a market.
The lesson from The Hague is therefore easy to formulate and difficult to implement. Ownership clauses belong in the legislation itself. Whoever wishes to introduce them retroactively must intervene in an existing contract. Conversely, every investor carries political risk, as a single regulatory decision can devalue a market segment within months. The ban on smokable hemp in Tennessee is the most recent example of this.
Frequently asked questions
What is the Dutch wiet experiment?
The trial with a closed coffeeshop chain has been running since December 15, 2023. Ten municipalities participate, including Breda, Tilburg, Maastricht, and Groningen, together with approximately 71 coffeeshops. Since April 7, 2025, these establishments may sell only regulated cannabis. Final evaluation is scheduled for 2027.
Why is the acquisition of CanAdelaar so controversial?
CanAdelaar is the largest of the ten licensed growers and supplies nearly all participating coffeeshops. The buyer is Canadian Cronos Group, in which tobacco corporation Altria holds approximately 41 percent. This would give the tobacco industry indirect access to the most important supplier for a state-controlled cannabis market.
What does Article 5.3 of the WHO Framework Convention on Tobacco Control state?
The provision obligates contracting parties to protect their health policies from the commercial interests of the tobacco industry. It is the reason tobacco corporations are excluded from advising on health legislation in many countries. According to the Dutch Cabinet’s interpretation, however, it does not apply to cannabis.
Can the government in The Hague still stop the acquisition?
The law does not provide for a direct blockade. A renewed Bibob review remains possible, which can be triggered by a change in ownership structure. However, it evaluates integrity and the risk of criminal entanglement. The health policy background of an investor does not factor into its assessment standards.
Could a tobacco corporation also enter the German market?
For cultivation associations, this is excluded because they must not operate for profit. The situation would be different with commercial pilot projects, which have not been politically implemented to date. Without an explicit regulation in the legislation, Germany would similarly lack a mechanism to prevent particular shareholders.
Sollten Tabakkonzerne am legalen Cannabismarkt beteiligt werden dürfen?
Sources: Responses from Ministers Hermans and Van Weel to parliamentary questions from CDA representatives Krul and Van den Brink dated August 25, 2026; Cannabisindustrie.nl on the acquisition, purchase price, and extended closing deadline; Rijksoverheid on participating municipalities in the experiment; Statement from Cronos Group dated December 9, 2025.
Branchen-Update
News, Analysen und Reportagen — mehrmals im Monat direkt in dein Postfach.
Folge uns
